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Assessing tumor physiology by dynamic contrast-enhanced nearinfrared spectroscopy
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a
Imaging Division, Lawson Health Research Institute, 268 Grosvenor Street, London, ON, Canada
N6A 4V2; bDept. of Medical Biophysics, Western University, 1151 Richmond Street, London, ON
Canada N6A 3K7; cImaging Program, Robarts Research Institute, 100 Perth Drive, London, ON
Canada N6A 5K8
ABSTRACT
The purpose of this study was to develop a dynamic contrast-enhanced (DCE) near-infrared spectroscopy (NIRS)
technique to characterize tumor physiology. Dynamic data were acquired using two contrast agents of different
molecular weights, indocyanine green (ICG) and IRDye 800CW carboxylate (IRDcxb). The DCE curves were analyzed
using a kinetic model capable of extracting estimates of tumor blood flow (F), capillary transit time (tc) and the amount
of dye that leaked into the extravascular space (EVS) – characterized by the extraction fraction (E). Data were acquired
from five nude rats with tumor xenografts (>10mm) implanted in the neck. Four DCE-NIR datasets (two from each
contrast agent) were acquired for each rat. The dye concentration curve in arterial blood, which is required to quantify
the model parameters, was measured non-invasively by dye densitometry. A modification to the kinetic model to
characterize tc as a distribution of possible values, rather than finite, improved the fit of acquired tumor concentration
curves, resulting in more reliable estimates. This modified kinetic model identified a difference between the extracted
fraction of IRDcxb, 15 ± 6 %, and ICG, 1.6 ± 0.6 %, in the tumor, which can be explained by the difference in molecular
weight: 67 kDa for ICG since it binds to albumin and 1.17 kDa for IRD. This study demonstrates the ability of DCENIRS to quantify tumor physiology. The next step is to adapt this approach with a dual-receptor approach.
Keywords: Dynamic-contrast enhanced, near-infrared spectroscopy, time-resolved, tumor, hemodynamics, adiabatic
approximation to the tissue homogeneity

1. INTRODUCTION
Increased angiogenesis, the physiological process of generating new blood vessels, is a characteristic of cancer.
Furthermore, because of the rapid growth of tumor vessels, they are often leaky compared to healthy tissue, and this can
be detected by dynamic contrast-enhanced (DCE) imaging methods, including magnetic resonance imaging (MRI) 1 and
computed tomography (CT)2. The methodology involves injecting a contrast agent into the blood system and using
serial imaging to monitoring the uptake and clearance of the contrast agent. With MRI and CT, DCE imaging has
become standard practice for assessing tumor hemodynamic properties in order to improve detection and grading of
cancer. However, only few studies have applied DCE to optical methods 3,4, despite the potential advantages that optics
provides in terms of safety, expense, and repeatability5.
Our group has previously developed DCE near-infrared spectroscopy (NIRS) for assessing cerebral hemodynamics by
using the optical contrast agent, indocyanine green (ICG) 6–8. Because the blood-brain barrier remains intact in this
application, cerebral blood flow, blood volume, and mean transit time are determined by a model-independent
deconvolution approach. However, it is expected in tumors that contrast agents will leak out of the vasculature due to
the poorly developed vessels9. To account for this feature, the deconvolution was performed using a model-based
approach that explicitly describes both blood flow and vascular permeability. A variation of the tracer kinetic model
that accounts for a distribution of tc values due to flow heterogeneity in tumors was also investigated. The purpose of
this study was to assess the ability of these models to properly characterize DCE data acquired by time-resolved (TR)NIRS. Experiments were conducted using human colon cancer xenographs grown subcutaneously in rats. Two contrast
agents with different molecular-weights, ICG and IRDye 800CW carboxylate (IRD cbx, LI-COR Biosciences), were
used.
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1.1 Tracer kinetic model
In all kinetic models, the concentration of the contrast agent within the interrogated tissue volume, for instance in a
tumor, can be modeled as a linear time-invariant system, given by the convolution equation:

Q(t )  F  C a (t )  R(t )

(1)

where * is the convolution operator, Q(t) is the amount of contrast agent within the tumor, F is blood flow, and Ca(t) is
the time-varying contrast agent concentration in arterial blood. The function R(t) is referred to as the impulse residue
function and it describes the amount of contrast agent remaining in the tumor following an idealized bolus injection at t
equal to 0. R(t) is defined by the specific kinetic models which are described below.
1.2 Adiabatic approximation to the tissue homogeneity model
Multiple tracer kinetic models have been proposed for describing R(t). For this application, we selected the adiabatic
approximation to the tissue homogeneity (AATH) model 10 because it accounts for a finite vascular transit time – unlike
compartmental models that assume it is negligible are due to instantaneous mixing – and the exchange of contrast agent
between blood and surrounding tissue. For the AATH model, R(t) is defined as follows:

R(t ) 

t  tc

1
E e

ke ( t tc )

(2)

t  tc

In Equation (2), the main components defined by the model are the capillary transit time, tc, and the fraction of contrast
agent extracted into the surrounding extravascular space during a single capillary transit, E. Also, the clearance rate of
extracted contrast agent from the tumor is governed by the rate constant k e. A caveat to the AATH model is transit
through the tumor vasculature is defined by a single capillary transit time. This is likely an oversimplification when the
model is applied to DCE data acquired from a large tissue volume.
1.3 Vascular dispersion model
A modification to the AATH model to account for the possibility of a distribution of t c values has been proposed11. In
this modification, referred to as the vascular dispersion (VD) model, the t c distribution is modeled as gamma
distribution:
t
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where the addition function, g(t), refers to the gamma distribution:
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and τ = tc/α. Compared to the AATH model, a new parameter, α, is introduced to characterize the width of vascular
dispersion (0 ≤ α-1 ≤ 1).

2. METHODS
2.1 Time-resolved near-infrared spectroscopy system
A time-resolved NIRS system consisting of picosecond pulsed diode laser (LDH-P-C-810, PicoQuant, Germany) was
used to acquire the DCE data8. The wavelength of the emitted light by the laser was 802 nm with an output power and
pulse repetition rate of 1.4 mW and 80 MHz, respectively. The laser beam was coupled into a 1.5-m long multimode
fiber (N.A. = 0.22, core = 400 µm, Fiberoptics Technology, Pomfret, Connecticut) and attenuated by two variable
neutral density filters (NDC-50-4M, Thorlabs, Newton, NJ) before transmitting through tissue. The diffuse light was
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detected by a 2-m fiber optic bundle (N.A. = 0.55, 3.6 mm active area and 4.7 mm outer diameter; Fiberoptics
Technology) coupled to a Peltier-cooled photomultiplier tube (PMC-100, Becker & Hickl, DE). Detection of single
photons generated electrical pulses (amplitude = 50-200 mV, width = 1.5 ns) that were transmitted to a time-correlated
single photon counting (TCSPC) module (SPC-134, Becker & Hickl, Germany). Before tissue data were acquired, the
instrument response function (IRF) was measured at the start of each experiment to account for light dispersion by the
TR-NIRS system12.
2.2 Rat model
All experimental procedures were approved by the Animal Use Subcommittee of the University of Western Ontario.
The LoVo human colon adenocarcinoma cell line (no. CCL-229; ATCC, Manassas, VA) was maintained in F12K
growth medium (Gibco, Burlington, Ontario, Canada), supplemented with 10% fetal bovine serum. Cells were
implanted onto the neck of male T-cell deficient athymic nude rats (Crl:NIH-rnu, Charles River
Laboratories,Wilmington,MA) between the ages of four to six weeks old. For implantation, the cells were suspended at
a concentration of 108 cells/ml in serum-free F12K medium with penicillin (100 U/ml) and streptomycin (100 µl/ml)
added before 150 microliters of the cell suspension (1.5 x 10 7 cells/rat) were implanted subcutaneously. Experiments
were conducted approximately two weeks after implantation when tumors had reached a minimal diameter of 10 mm.
2.3 Experimental setup
Rats were anaesthetized by inhaling 4% isoflurane before inserting a catheter into a tail vein, which was used to collect
blood samples and to inject contrast agents. The emission and detection optical fibers were placed transversely onto the
tumor surface using in-house developed probe holders. The diameter of each tumor was measured by callipers. Four
sets of DCE data were collected per rat and each set contained a total acquisition time of 5 minutes. Successive injection
of contrast agents was separated by roughly 30 minutes to allow contrast agent clearance from the previous injection.
The first two injections were ICG due to its faster clearance, followed by the two IRDcxb injections. The contrast agents
were intravenously injected as a bolus at a concentration of 0.7 mg/kg dissolved in 0.5 ml sterile water. Serial tissue
tracer concentration measurements were made every 0.4 s for 15 s prior to and 5 min following injection of the contrast
agent. The arterial input function (AIF) was measured concurrently by a dye densitometer attached to a rear foot (DDG
2001, Nihon Kohden, Japan).

Inhaled Gas
02/Medical

Air
+ Isoflurane

Photomultiplier
Tube

Laser Power
Source

Tail Vein Catheter

Figure 1. A schematic diagram of the experimental setup

2.4 Data Analysis
Quantification of tumor optical properties was performed by fitting the solution to the diffusion equation for
transmittance through an infinite homogenous slab13. For each injection, the concentration of contrast agent in the
tumor, Q(t), was determined in two steps. First, the baseline optical properties (the absorption coefficient, µ a, and the
reduced scattering coefficient, µs’) were determined from temporal point spread functions (TPSFs) acquired for 30
seconds before injecting a contrast agent. Second, the time-varying change in µa caused by the injected contrast agent
was determined by analyzing each TPSF in the time series by fitting for µa and setting µs’ to its baseline value. Using
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the known extinction coefficient of the active contrast agent at 802 nm, the time-dependent change in µa(t) was
converted into concentration. Simultaneously, data obtained by the dye densitometer were converted into the arterial
contrast agent concentration, Ca(t), by using the measured total hemoglobin blood concentration (tHb) for each rat and
the molecular weight of the contrast agent.
The kinetic models were fit to the DCE data by nonlinear optimization (MATLAB® function fminsearch). The fitting
parameters were F, tc, E, and ke for both models. The VD model also included the additional fitting parameter α to
account for the distribution of capillary transit times. All parameters were constrained to be positive, the upper limit of
both E and α-1 was set to 1. To account for differences in the arrival time of contrast agent between tissue and arterial
blood, the fitting was repeated while shifting the arterial data by the sampling interval (0.4 s). The optimal time shift
was selected based on the minimum sum of squared differences between the data and the model. From the best-fit
estimates of the model parameters, tumor blood volume (Vc) was determined using the central volume principle,
Vc = F·tc and the permeability surface-area (PS) product was determined from E = 1-e-PS/F.

3. RESULTS AND DISCUSSION
3.1 Physiological Parameters
A total of 5 rats were used in this study and all errors are given as standard error. Table 1 contains the individual
physiological parameters for each individual rat. The average values were 310 ± 20 g for weight, 13 ± 4 mm for tumor
diameter, 95 ± 3 % for arterial oxygen saturation (SO2), 360 ± 30 beats per minute (BPM) for heart rate, and 12.7 ± 1.0
g/dl for tHb.
Table 1. Physiological parameters for each rat within the study.

Rat
1
2
3
4
5
Average

Weight (g)
286
312
291
332
336
310 ± 20

Diameter (mm)
12
11
21
12
10
13 ± 4

SO2 (%)
95
97
91
96
98
95 ± 3

Heart Rate (BPM)
372
365
360
375
306
360 ± 30

tHb (g/dl)
12.8
12.8
12.4
11.5
14.2
12.7 ± 1.0

To minimize dead-time and pile-up effects, the maximum count rate was restrained to approximately 1% of the
maximum output power by adjusting the neutral density filters to control the attenuation of the emitted light. In all rats,
the maximum count rate was approximately 800 kHz, except for Rat 3. The tumor diameter for this rate was roughly
double the average size and the maximum count rate was 265 kHz. Upon visual inspection, this tumor had a large
necrotic center, which limited the maximum count rate. However, the signal-to-noise ratio of the acquired DCE data
was still quite high.
3.2 Optical Properties
Table 2 lists the retrieved optical properties of the tumors obtained by fitting the solution to the diffusion equation for
transmittance through an infinite homogenous slab.
Table 2. Measured tumor optical properties by the TR-NIRS system.

Rat
1
2
3
4
5
Average

µs' (cm-1)
17.98
28.03
30.95
21.35
12.08
22 ± 8

µa (cm-1)
1.07
1.45
1.52
0.99
0.84
1.2 ± 0.3
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The average optical properties, µs' and µa, were 22 ± 8 and 1.2 ± 0.3 cm-1, respectively. These values are in reasonable
agreement with a previous study: 15 ± 7 and 1.4 ± 0.7 cm-1 for µs' and µa, respectively14. Differences between the
studies could be partly attributed to the difference in cell lines. Rat colon adenocarcinoma cells were used by Van
Hillegersberg et al, while the current study used Lovo human adenocarcinoma cells. Furthermore, measurements by
Van Hillegersberg et al. were conducted on ex vivo samples using the integrating sphere technique, compared to in vivo
TR-NIRS measurements used in the current study.
3.3 Sample of Measured Concentration Curves
Figure 2 shows an example of arterial and tumor contrast agent concentration curves, which were acquired
simultaneously during the passage of an ICG bolus.
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Figure 2. Arterial (red) and tumor (black) contrast agent concentration curves measured by the dye densitometer and TR-NIRS
system, respectively, following a bolus injection of ICG.

In comparison, Figure 3 depicts the arterial and tumor contrast agent concentration curves acquired with IRDcxb. In both
figures, the distinctive hump occurring approximately at 20 seconds after contrast agent injection reflects the initial
passage of the bolus through the interrogated tissue volume and is characteristics of the finite capillary transit time.
After the first pass, the tissue concentration curve for ICG mirrors the slow washout of contrast agent from blood. In
contrast, the continual rise of the tissue concentration curve for IRD cxb reflects the extraction of the dye into the
interstitial space of the tumor. This visible difference in the clearance curves for the two dyes reflects the difference in
molecular weight. That is, ICG due to its binding with albumin is too large to penetrate tumor vessel walls.
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Figure 3. Arterial (red) and tumor (black) contrast agent concentration curves measured by the dye densitometer and TR-NIRS
system, respectively, following a bolus injection of IRDcxb.
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3.4 Fitted Parameter Data
For each rat there were two injections of each contrast agent, ICG and IRDcxb. Tables 3 and 4 list the fitting parameters
for the AATH and VD models when applied to ICG data, respectively. Similarly, Tables 5 and 6 list the fitting
parameters for the two models when applied to IRD cxb data. Note, Rat 2 was not included in the ICG results (Tables 3
and 4) because only IRDcxb was injected. All comparisons were conducted by multivariate analysis of variance
(MANOVA) run in IBM SPSS Statistics 20 (significant difference was defined as p<0.05).
Table 3. Retrieved fitting parameters extracted by the AATH model for ICG clearance data.

Rat
1
3
4
5
Average

F (ml/g/min)
0.371
0.194
0.177
0.239
0.25 ± 0.09

tc (s)
7.0
12.3
12.7
6.8
10 ± 3

ke (min-1)
2.9
2.0
0.2
3.6
2±1

E
0.27
0.33
0.04
0.30
0.2 ± 0.1

Vc (ml/g)
0.043
0.040
0.038
0.027
0.04 ± 0.01

PS (ml/g/min)
0.117
0.078
0.007
0.085
0.07 ± 0.05

Table 4. Retrieved fitting parameters extracted by the VD model for ICG clearance data.

Rat
1
3
4
5
Average

F (ml/g/min)
0.46
0.23
0.22
0.29
0.3 ± 0.1

tc (s)
7.8
14.7
10.8
7.6
10 ± 3

E
0.0100
0.0175
0.0240
0.0125
0.016 ± 0.006

ke (min-1)
0.154
0.019
0.012
0.005
0.05 ± 0.07

α-1
0.80
0.65
0.45
0.68
0.6 ± 0.1

Vc (ml/g)
0.060
0.056
0.040
0.037
0.05 ± 0.01

PS (ml/g/min)
0.0020
0.0018
0.0023
0.0016
0.0019 ± 0.0003

Comparing the values in Tables 3 and 4, significant differences between the two models for ICG clearance data were
observed for E, ke, and PS (α-1 was not used in the MANOVA). In general, the fit of the AATH model was much poorer
than the VD model, particularly during the first pass, as illustrated in Figure 4. A consequence of the poor fit is
statistically greater E values for the AATH model; however, ICG can be considered a macromolecular contrast agent
due to the binding albumin. Therefore, its uptake into the tumor extravascular space is likely going to be small,
suggesting that the AATH model overestimates the extraction fraction of ICG. In turn, this error leads to erroneous
estimates of the extracted clearance rate (ke) and the calculated PS product.
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Figure 4. Representative tumor ICG concentration curve (black) and the fit of the (A) the AATH model (red) and (B) the VD
model (red).

The fit of the AATH model also appeared worse for the IRD cxb clearance data. However, despite the poorer fit, there
were no significant differences observed in any of the fitting parameters listed in Tables 5 and 6 for IRD cxb. This is
likely because of differences in the kinetic properties of the two dyes. IRD cxb is considerably smaller than ICG and will
likely leak into the extravascular space.
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Table 5. Retrieved fitting parameters extracted by the AATH model for IRDcxb clearance data.

Rat
1
2
3
4
5
Average

F (ml/g/min)
0.293
0.248
0.226
0.144
0.162
0.21 ± 0.06

tc (s)
11.0
15.8
13.9
18.1
8.8
14 ± 4

E
0.189
0.346
0.188
0.224
0.161
0.22 ± 0.07

ke (min-1)
0.098
0.145
0.154
0.085
0.171
0.13 ± 0.04

Vc (ml/g)
0.054
0.065
0.052
0.043
0.024
0.05 ± 0.02

PS (ml/g/min)
0.027
0.046
0.020
0.016
0.012
0.02 ± 0.01

Table 6. Retrieved fitting parameters extracted by the VD model for IRDcxb clearance data

Rat
1
2
3
4
5
Average

F (ml/g/min)
0.379
0.304
0.340
0.211
0.188
0.28 ± 0.08

tc (s)
9.4
15.2
10.1
12.9
8.0
11 ± 3

E
0.129
0.247
0.110
0.132
0.129
0.15 ± 0.06

ke (min-1)
0.053
0.076
0.096
0.033
0.140
0.08 ± 0.04

α-1
0.94
1.00
0.98
0.97
0.46
0.9 ± 0.2

Vc (ml/g)
0.059
0.077
0.057
0.045
0.025
0.05 ± 0.02

PS (ml/g/min)
0.023
0.038
0.017
0.013
0.011
0.02 ± 0.01

Comparing the best-fit parameters from the AATH model between the two contrast agents (Tables 3 and 5), a
significant difference was only observed for ke. However, the variability in some of the other parameters, notably E,
was large due to the poor fit of the model. In contrast, significant differences for E and the PS product were found when
comparing the best-fit estimates from the VD model (Tables 4 and 6). This result agrees with the expected difference
between these contrast agents considering the difference in molecular weight: 67 and 1.17 kDa for ICG and IRDcxb,
respectively.
3.5 Mean Difference
Since the VD model demonstrates a better fit, the percent mean difference was determined for each parameter from the
two trials (Table 7). The largest variations were observed for E, ke, and PS for ICG, which is understandable
considering the low extraction of this contrast agent. However, a largest variation for k e was also found for IRGcxb,
indicating that this is the least reliable fitting parameter.
Table 7. The relative mean difference (%) between trials for each fitting parameters from the vascular dispersion model applied to
clearance data from both contrast agents.

Contrast Agent
F
tc
E
ke
α
Vc
PS

ICG (%)
12
14
84
146
21
7
63

IRD (%)
30
13
9
38
1
13
3
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4. CONCLUSION
In this work, the ability of two tracer kinetic models, the AATH model and the VD model, to characterize tumor
hemodynamics was investigated. The difference between the two models is the original AATH model restricts the
capillary transit time tc to a single value, while the VD model includes an additional parameter to account for the
possibility of a distribution of tc values. The results indicated that this modification improved the tumor concentration
curves fitting, particularly for the first pass of the contrast agent. With an appropriate model in base, this approach could
be used to characterize the hemodynamic properties of different cancers and their response to treatments. Tumor blood
flow and vascular permeability likely play a significant role in the efficacy of therapeutic drugs since they will affect
drug delivery. This method could be combined with the quantitative receptor imaging approach proposed by Tichauer et
al. to further enhance the characterization of cancer by optical techniques15.
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